Selective oxidation of 5-methylcytosine by TET-family proteins
The present invention provides for novel methods for regulating and detecting the cytosine methylation status of DNA. The invention is based upon identification of a novel and surprising catalytic activity for the family of TET proteins, namely TET1, TET2, TET3, and CXXC4. The novel activity is related to the enzymes being capable of converting the cytosine nucleotide 5-methylcytosine into 5-hydroxymethylcytosine by hydroxylation.
1. A method comprising: administering to a subject, an agent that modulates activity of an enzyme that mediates conversion of a methylated cytosine residue to a modified base, wherein said subject has a cancer or is at risk of developing said cancer, wherein said modified base comprises a hydroxymethylated cytosine residue and wherein said agent comprises a siRNA.
2. The method of claim 1 , wherein said subject is a mammal.
3. The method of claim 2 , wherein said methylated cytosine residue comprises a 5-methylcytosine.
4. The method of claim 2 , wherein said hydroxymethylated cytosine residue is a 5-hydroxymethylcytosine.
5. The method of claim 2 , wherein said cancer is leukemia.
6. The method of claim 5 , wherein said leukemia is myeloid leukemia.
7. The method of claim 2 , wherein said agent inhibits activity of said enzyme.
8. The method of claim 2 , wherein said enzyme comprises a TET family enzyme, functional TET family derivative, or a TET catalytically active fragment.
9. The method of claim 8 , wherein said TET family enzyme comprises TET1, TET2, TET3 or CXXC4.
10. The method of claim 8 , wherein said functional TET family derivative comprises SEQ ID NO: 1.
11. The method of claim 8 , wherein said TET catalytically active fragment comprises SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, or SEQ ID NO: 5.